Entering text into the input field will update the search result below

Eli Lilly & Co. (NYSE:LLY): Q2 EPS of $1.12 beats by $0.10. Revenue of $5.3B (+0.8%)...

Jul. 22, 2009 6:45 AM ETEli Lilly and Company (LLY)LLYBy: Rachael Granby, SA News Editor
Eli Lilly & Co. (NYSE:LLY): Q2 EPS of $1.12 beats by $0.10. Revenue of $5.3B (+0.8%) in-line. Raises FY '09 EPS guidance to $4.20-4.30 vs. $4.00-4.25 previous guidance. (PR)

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About LLY

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Eli Lilly and Company
Johnson & Johnson
Merck & Co., Inc.
Roche Holding AG
AstraZeneca PLC
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.